ClinicalTrials.Veeva

Menu

Ventripoint Single Ventricle Study

Duke University logo

Duke University

Status

Enrolling

Conditions

Single-ventricle
Congenital Heart Disease

Treatments

Device: Transthoracic Echocardiogram or Cardiac MRI
Device: Ventripoint Echocardiogram

Study type

Interventional

Funder types

Other

Identifiers

NCT05262907
Pro00108548

Details and patient eligibility

About

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

Full description

The accuracy of current echocardiographic techniques for measuring ventricular size and function are limited by geometric assumptions, which are particularly problematic in malformed hearts or functional single ventricles, as well as the inability to visualize the entire heart at one time from a single imaging window, and higher heart rates degrading 3D imaging volume rates. This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles, including a comparison to the gold standard of cardiac MRI.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI.

Exclusion criteria

  • Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Ventripoint 3D Echocardiogram
Experimental group
Description:
Ventripoint 3D Echo performed on subject to validate technology for use in single ventricle patients.
Treatment:
Device: Ventripoint Echocardiogram
Transthoracic Echocardiogram or Cardiac MRI
Active Comparator group
Description:
Non-invasive imaging of the heart to evaluate structure and function.
Treatment:
Device: Transthoracic Echocardiogram or Cardiac MRI

Trial contacts and locations

1

Loading...

Central trial contact

Joan Wilson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems